In the same context, it was noticed that IBD patients had lower levels of fatty acid-binding protein 5 (FABP5), directly associated with alterations in compounds involved in energy metabolism, including pyrophosphatase, visfatin, and UDP-glucose 6-dehydrogenase, as well as disease severity. This evidence concerns the gene UGDH and inflammatory bowel disease.